Lazard Asset Management Portfolio holdings
AUM
$72.7B
1-Year Return
14.89%
This Quarter Return
+0.1%
1 Year Return
+14.89%
3 Year Return
+61.14%
5 Year Return
+112.7%
10 Year Return
+262.42%
AUM
$68.4B
AUM Growth
-$6.42B
(-8.6%)
Cap. Flow
-$10.6B
Cap. Flow
% of AUM
-15.46%
Top 10 Holdings %
Top 10 Hldgs %
25.74%
Holding
2,627
New
281
Increased
825
Reduced
894
Closed
234
Top Buys
| 1 |
Eli Lilly
LLY
|
+$404M |
| 2 |
Merck
MRK
|
+$276M |
| 3 |
Jacobs Solutions
J
|
+$255M |
| 4 |
Equifax
EFX
|
+$241M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$209M |
Top Sells
| 1 |
Microsoft
MSFT
|
+$702M |
| 2 |
Johnson & Johnson
JNJ
|
+$536M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$520M |
| 4 |
Marvell Technology
MRVL
|
+$448M |
| 5 |
Amazon
AMZN
|
+$344M |
Sector Composition
| 1 | Technology | 26.04% |
| 2 | Financials | 14.62% |
| 3 | Healthcare | 12% |
| 4 | Industrials | 10.54% |
| 5 | Consumer Discretionary | 9.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1601
Bioventus
BVS
$468M
| $110K | ﹤0.01% |
10,518
-2,098
| -17% | -$21.9K |
|
1602
JELD-WEN Holding
JELD
$537M
| $110K | ﹤0.01% |
13,569
-689
| -5% | -$5.59K |
|
1603
Moderna
MRNA
$9.46B
| $110K | ﹤0.01% |
2,669
-11,516
| -81% | -$475K |
|
1604
Alaska Air
ALK
$7.22B
| $109K | ﹤0.01% |
1,687
-2,318
| -58% | -$150K |
|
1605
OraSure Technologies
OSUR
$238M
| $109K | ﹤0.01% |
30,426
-94,005
| -76% | -$337K |
|
1606
Uranium Energy
UEC
$5.6B
| $109K | ﹤0.01% |
+16,372
| New | +$109K |
|
1607
CEMIG Preferred Shares
CIG
$5.81B
| $107K | ﹤0.01% |
60,798
| – | – |
|
1608
HP
HPQ
$26.5B
| $106K | ﹤0.01% |
3,251
+1,611
| +98% | +$52.5K |
|
1609
Iron Mountain
IRM
$28.8B
| $106K | ﹤0.01% |
1,017
+10
| +1% | +$1.04K |
|
1610
Red River Bancshares
RRBI
$431M
| $106K | ﹤0.01% |
+1,981
| New | +$106K |
|
1611
InMode
INMD
$949M
| $105K | ﹤0.01% |
6,291
+6,190
| +6,129% | +$103K |
|
1612
Betterware México
BWMX
$508M
| $104K | ﹤0.01% |
9,343
-19,388
| -67% | -$216K |
|
1613
Red Rock Resorts
RRR
$3.66B
| $104K | ﹤0.01% |
2,267
-9,042
| -80% | -$415K |
|
1614
Supernus Pharmaceuticals
SUPN
$2.59B
| $104K | ﹤0.01% |
2,887
-115
| -4% | -$4.14K |
|
1615
Atkore
ATKR
$2.04B
| $103K | ﹤0.01% |
1,237
-81
| -6% | -$6.75K |
|
1616
Southside Bancshares
SBSI
$917M
| $103K | ﹤0.01% |
+3,265
| New | +$103K |
|
1617
Century Communities
CCS
$1.99B
| $101K | ﹤0.01% |
1,396
-9,371
| -87% | -$678K |
|
1618
Cipher Mining
CIFR
$4.03B
| $101K | ﹤0.01% |
22,194
+22,127
| +33,025% | +$101K |
|
1619
Universal Technical Institute
UTI
$1.48B
| $101K | ﹤0.01% |
+3,953
| New | +$101K |
|
1620
Bloom Energy
BE
$14.7B
| $99K | ﹤0.01% |
4,500
-15,063
| -77% | -$331K |
|
1621
Five Below
FIVE
$8.05B
| $99K | ﹤0.01% |
+950
| New | +$99K |
|
1622
Travere Therapeutics
TVTX
$2.43B
| $99K | ﹤0.01% |
+5,717
| New | +$99K |
|
1623
ANI Pharmaceuticals
ANIP
$2.11B
| $97K | ﹤0.01% |
1,781
-3,819
| -68% | -$208K |
|
1624
Gossamer Bio
GOSS
$707M
| $97K | ﹤0.01% |
107,470
+106,142
| +7,993% | +$95.8K |
|
1625
TransUnion
TRU
$17.5B
| $97K | ﹤0.01% |
1,049
+799
| +320% | +$73.9K |
|